Silmmal'y Anti-DNA antibodies, specifically those that stain nuclei in a homogenous nuclear (HN) fashion, are diagnostic of systemic lupus erythematosus (SLE) and the MRL-Ipr/Ipr SLE murine model.
S
LE is a complex disease that has a spectrum of clinical manifestations thought to be the consequence of a dysfunctional immune system. Autoantibodies, specifically anti-DNA antibodies, are the serological hallmark of SLE (1) . Although the etiology of serum autoantibodies is unknown, their presence has been attributed to a defect in the regulation of self-reactive B and/or T cells (2) (3) (4) (5) (6) . Studies using selfreactive Ig transgenic (tg) 1 mice have demonstrated that B cells are normally subject to tolerance induction either by deletion or functional inactivation (7, 8) . It is not clear, however, how the rules that have been established for B cell tolerance to exogenous antigens or neo-self antigens apply to antigens targeted in autoimmunity.
Anti-DNA antibodies from both SLE patients and animal models of SLE are heterogeneous in terms of their specificity for DNA and DNA/protein complexes (1, (9) (10) (11) (12) . Antibodies that stain nuclei and mitotic figures in a homogeneous fashion in the anti-nuclear antibody (ANA) assay are designated as anti-homogeneous nuclear (anti-HN). The presence of this subset of anti-DNA antibodies is one of the diagnostic criteria for SLE (13) . Here we address the regulation of various anti-DNA antibodies in nonautoimmune mice and how this may be disrupted in autoimmune animals. Our approach has been to generate anti-DNA Ig tg mice and cross the anti-DNA Ig tg onto both nonautoimmune (BALB/c) and autoimmune (MRL-Ipr/lpr) genetic backgrounds.
The MRL-lt, r/lpr mouse provides a well characterized model of human SLE, developing anti-DNA antibodies and a lupuslike nephritis (10) (11) (12) . The Ipr mutation was recently shown I Abbreviations used in this paper: ANA, anti-nuclear antibody; anti-HN, anti-homogenous nuclear; tg, transgenic.
to be the consequence of an insertion of a retrotransposon (ETn) into the second intron of the gene encoding the membrane antigen Fas (14) (15) (16) . The resulting defect in mRNA splicing prevents production of normal levels of Fas protein.
In mice homozygous for the Ipr mutation (Ipr/lpr mice) only 2-10% of Fas mKNA is wild type (15, 16) , and Fas protein has not been detected in cell populations such as thymocytes and activated peripheral B and T cells which normally express Fas (17). The observation that Fas is a receptor whose engagement on certain transformed cell lines results in apoptosis (18) has led to the suggestion that a defect in apoptosismediated negative sdection is the cause of autoimmunity in MRL-lpr/Ipr mice (14) . However, the involvement of Fas in selection of the immune repertoire is controversial. Several reports have indicated that MRL-Ipr/Ipr mice are not grossly defective in negative selection of T cells (19, 20) and are also capable of mediating appropriate positive selection (20) , whereas other studies report defects in the induction and maintenance of T cell tolerance (21, 22) . Whether the Ipr mutation has a direct effect on B cell repertoire formation in MR.b lpr/lpr mice is not known. However, since the lpr mutation when crossed to a number of mouse strains results in the induction of various autoantibodies (including anti-DNA antibodies) (23) , the lpr mutation appears to have a direct role in the genesis of autoantibodies. We have used an Ig H chain tg that increases the frequency of anti-DNA autoantibodies to address whether the production of anti-DNA antibodies in MRL-Ipr/lpr mice is the consequence of a breakdown of B cell tolerance. The design of our Ig tg was based on the observation that a particular H chain, VH3H9, has been recurrently isolated from anti-DNA antibodies arising spontaneously in MRDlpr/Ipr mice, indicating that this VH has inherent DNA-binding capacity (24) .
Moreover, this VH can pair with many different VL genes to give anti-DNA antibodies as well as non-DNA binding antibodies (25, and this report) . By crossing the VH3H9 tg onto BALB/c and MRL-Ipr/lpr genetic backgrounds and assessing the specificity of their peripheral B cell repertoires, we have identified the kinds of anti-DNA antibodies that are present in normal mice and the kinds that are only found in the autoimmune-prone animals. We found that anti-HN B cells were undetectable in nonautoimmune-prone VH3H9 tg mice, whereas they were readily retrievable as hybridomas and their Ig was evident in the sera of MlkL-lpr/Ipr VH3H9 tg mice. This suggests that nonautoimmune animals actively delete anti-HN-specific B cells, and that MRI~Ipr/lpr mice are defective in this process.
Materials and Methods
Mice. The generation of VH3H9 tg mice using a construct consisting of the MRL.lpr/lpr-derived 3H9 V region combined with the BALB/c/z constant region has been described previously (26) .
The tg has been backcrossed onto the nonautoimmune BALB/c and the SLE-prone MRLlpr/Ipr backgrounds: homozygosity for the Ipr mutation infas was determined for mice on the MRL background by scoring for development of lymphadenopathy and the presence of (CD4-, CDS-, CD3 +) double negative T cells that characterize Ipr/lpr mice (12) . In addition, the earliest backcross mouse (MRL1 at backcross 2) was verified as Ipr/lpr by PCR amplification which distinguishes the Ipr allele from the wild-type allele (data not shown). Each VH3H9 tg mouse is at least backcross 2, which corresponds to three matings onto and *88% of a given genetic background. Mice carrying the VH3H9 tg were identified by amplification of tail DNA using the VH3H9 tg specific primers (26): VH3H9 Leader 5'CTGTCAGGAACTGCAGGTAAG-G3'; VH3H9CDR3 5'CATAACATAGGAATATTTACTCCTCGC-3'. Non-tg MRL-Ipr/Ipr mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and BALB/cJ mice were purchased from Charles River Laboratories (Wilmington, MA).
B CelIHybridoma Production.
Spleen calls from mice were fused without further manipulation to the Ig-myeloma Sp2/0 (27) . Cells were plated at limiting dilutions and only wells beating single colonies were expanded for analysis.
ELISA Assays. Isotype and Ig concentration were determined using indirect solid-phase ELISA assays, as described previously (26) . Isotype was determined using anti-g or anti-X L chain antibodies (Southern Biotechnology Associates, Birmingham, AL) as the primary antibody, then developing with alkaline phosphatase-labded anti-IgM or anti-(IgGl+IgG2a+IgG2b+IgG3+IgA) antibodies (Southern Biotechnology Associates). Ig concentration was determined by comparing samples to a titrated isotype-matched standard. Binding to ssDNA was detected in the same manner, except that belled and snap-chilled sonicated salmon sperm DNA (Sigma Chemical Co., St. Louis, MO) at 14/xg/well in PBS was used in place of primary antibodies, as described previously (26) . Values of five times the negative control were considered positive.
Preparation and Analysis of DNA. DNA was prepared from confluent hybridoma cell cultures using proteinase K digestion followed by phenol extraction. 10/~g of DNA was then digested with either EcoRI or BamHI, size separated, and blotted onto Zeta-probe blotting membrane (Bio-Rad, Richmond, CA). DNA rearrangements at the H chain locus were detected by probing EcoRi membranes with pJ11 (28) , and at the L chain locus by probing BamHI membranes with pECr (29) .
Anti-HN Antibody Detection. The presence of anti-HN antibody in sera and hybridoma supernatants was detected using permeabilized HEP-2 cells as the substrate (Antibodies Incorporated, Davis, CA). The manufacturer's instructions were followed except for substitution of undiluted supernatants when hybridomas were assayed.
Sequence Analysis of lg H and L Chain mRNA. Cytoplasmic
RNA was isolated from ml05 hybridoma cells by NP-40 lysis followed by proteinase K digestion, phenol/chloroform extraction, and ethanol precipitation. Constant region-specific oligonucleotide primers were used to direct synthesis of cDNA copies of the H and L chain V regions, which were then amplified in the PCR using the same constant region primers and degenerate primers that hybridize to the 5'-ends of H and L chain V regions as described previously (30) , except that unffactionated cDNA products were subjected to amplification. The dsDNA copies of the H and L chain V regions were fractionated by agarose gel electrophoresis, isolated using GeneClean (Biol01, distributed by American Bioanalytical, Nafick, MA), and directly sequenced using Sequenase (USB, Cleveland, OH) and either the constant or V region-specific primer that was used in the amplification reaction to direct synthesis. Sequence was read and translated using the Wisconsin program (31) . Sequence comparison was carried out by searching the EMBL/GenBank/DDBJ databases and Kabat et al. (32) .
Primers. Production ofcDNA was carried out using a 3' primer of interest (e.g., C r for r L chains). Amplification utilized 3' and 5' primer pairs as indicated for a given chain. Sequencing was carried out using either the 3' or 5' primer, and sequence reverse complimented as appropriate. Primer pairs used were the following: r (3') C r: 5'GTTGGTGCAGCATCAGC 3" Primers described previously were the following: L5' was adapted from L4/L5 (33); X 1 primers were derived from the germline X1 leader and CX1 sequence reported in (34) ; similarly the C~,2-3 primer was derived from sequence reported in (35) ; the VXX primer was reported by (36) ; the IgM and C'ycross primers were reported in (37) ; whereas the VH5'I primer was taken from (38) . To verify the use of the VH3H9 tg with the "y constant region, cDNA was made using C3~cross, then a nested primer specific for CDR3 of VH3H9 was used with VH5'I to amplify. The VH3H9 CDR3 primer is the same used in genotyping mice.
Results and Discussion
The VH3H9 tg paired with endogenous L chains generates a range of anti-DNA and non-DNA reactive antibodies. We have used this tg as a means of following the fate of anti-DNA B cells in nonautoimmune and autoimmune-prone mice to address whether the production of anti-DNA antibodies in SLE is the consequence of a breakdown in B cell tolerance. The tg has been backcrossed onto the nonautoimmune BALB/c and the SLE-prone MRL-Ipr/lpr backgrounds for the number of generations indicated in Table 1 . Serum specificity for each mouse was determined using an ELISA assay for ssDNA binding and the HEP-2 immunofluoresence assay for detection of anti-HN antibodies as described in Fig. 1 . The BALB2 mouse has been previously reported (25) .
selected for homozygosity of the lpr mutation. Each VH3H9 tg mouse is at least backcross 2 which corresponds to having "~88% of a given genetic background. Features of the mice used in this study are listed in Table 1 .
Specificity of VHSH9 B Cells in BALB/c and Mgl.dpr/lpr
Mice. The VH3H9 tg can pair with different L chains from the endogenous pool to produce three different specificities: non-DNA Igs, anti-ssDNA Igs, and anti-HN Igs (25, 26) .
To assess how BALB/c and MRL-lpr/Ipr mice regulate the production of different kinds of antibodies in their serum, individual mice were examined for the ability of their serum to bind ssDNA by ELISA, and to display anti-HN ANAs. Anti-HN Igs are a reliable indicator of SLE that distinguishes the sera of MRDlpr/Ipr mice from those of nonautoimmune strains (10, 39) . In addition, the anti-HN subset of anti-DNA antibodies has been implicated in renal pathology (39). As was previously described, the serum from BALB/c VH3H9 tg mice showed undetectable binding to ssDNA and lacked anti-HN Ig (26, and this report). In contrast, 24 of 27 MRLIpr/Ipr VH3H9 mice contain anti-ssDNA and anti-HN serum Igs, three of which are described in Table 1 To analyze the B cell repertoires of these mice in greater detail, B cell hybridomas were generated from spleen cells from each of these VH3H9 tg mice (i.e., two BALB/c VH3H9 tg and three MKL-Ipr/Ipr VH3H9 tg mice) as well as from seven MKL-Ipr/Ipr mice that do not bear the VH3H9 tg. The MRD Ipr/Ipr-derived hybridoma panels were all generated with unmanipulated spleen cells. The BALB1 spleen cells were likewise not activated before fusion to facilitate comparison to a large set of hybridomas that had been derived from spontaneous B cell fusions in various SLE-prone mice panel was generated using spleen cells that had been activated in vivo with LPS before fusion, as was described previously (25) . All of the hybridomas that were retrieved from the BALB/c VH3H9 tg mice were of independent origin as determined by Southern blot analysis using the rearrangement patterns of both the Ig H and L chain loci (data not shown).
Among the MKL-lpr/lpr VH3H9 tg hybridomas, however,
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IgM Table 2 ). The most striking difference between the BALB/c and the MRL-Ipr/lpr-derived hybridoma panels is that anti-HN hybridomas were recovered from the MKLIpr/Ipr VH3H9 tg mice, but not from the BALB/c VH3H9 tg mice (Table 2) . Anti-ssDNA hybridomas, on the other hand, were recovered from both sets of mice. It is noteworthy that the VH3H9 tg greatly augmented the frequency of both anti-ssDNA and anti-HN hybridomas in the MKL-IFr/Ipr background as compared with MKL.Ipr/IFr tg(-) mice.
Specificity for ssDNA was also increased among hybridomas from the BALB/c VH3H9 tg mouse as compared with frequencies reported for BALB/c tg(-) mice (42, 43) . The increased frequency of these specificities is consistent with previous observations (25, 26) that the VH3H9 tg paired with a variety of endogenous L chain genes give antibodies that can bind to DNA.
Together, these specificity data support previous conclusions that normal mice actively regulate anti-DNA antibodies (18, 26, 44) . The manifestations of this regulation in BALB/c VH3H9 tg mice appear to vary for ssDNA-versus HN-specific B calls. Anti-ssDNA B cells dominate the B cell repertoire of BALB/c VH3H9 tg mice, yet the tg mice do not have serum anti-DNA antibodies (26) . As described previously (26) , this suggests a functional block in their ability to differentiate into antibody-secreting cells. Anti-HN B cells, however, were not rescued in hybridoma panels nor was their Ig present in the sera, suggesting that they are deleted from The specificity was determined for hybridomas in each panel using an ELISA assay for ssDNA binding and the HEP-2 immunofluoresence assay for detection of anti-HN antibodies as described in Fig. 1 . Specificity of the total hybridoma panels for the VH3H9 tg mice and a panel of non-tg MRL-Ipr/Ipr mice is presented. The BALB2 mouse has been previously reported (25) . Both the BALB1-and BALB2-derived hybridomas have the same specificity profile as a third VH3H9 tg hybridoma panel from a nonautoimmune background described previously (26) . Genetic Basis.for Anti-DNA Antibodies in VH3H9 tg Mice.
To address the genetic basis for the presence of anti-HN hybridomas in the MRblpr/Ipr VH3H9 tg pands and their absence in the BALB/c VH3H9 tg panels, hybridomas were analyzed for the sequences of their H and L chain Ig V region mRNAs. Sequence analysis of the LPS-activated hybridomas has been previously described and is not presented here (25) . All of the hybridomas from the BALB1 and MRL3 fusions were analyzed. A subset of hybridomas from the larger MRL1 and MRL2 panels were sequenced, with an emphasis on those that gave anti-HN reactivity. A fraction of hybridomas from both BALB/c and MRL-Ipr/Ipr mice were found to express mixed L chain sequences, most likely due to the expression of out-of-frame transcripts that were amplified in the PCR reactions used for sequencing. In addition, whereas the BALB/c VH3H9 tg--derived hybridomas all exclusively expressed an unmodified VH3H9 tg-encoded H chain, ap- To definitively assign specificity to gene segment usage, we have confined our discussion of the sequence analysis to those hybridomas that only expressed one H chain gene and only one K and/or ~, L chain. Table 3 shows the hybridomas that fit these criteria. The specificity of the hybridomas that express the VH3H9 tg and a single VL (or in two cases the VH3H9 tg with a K and a h VL) are presented. the MRDIpr/lpr VH3H9 tg sequences use the same V~c12a gene. The frequency of VIc12a in the MRL-Ipr/lpr VH3H9 tg hybridomas may actually be an underestimate of its representation in the total hybridoma panel since we biased our sequence analysis toward anti-HN hybridomas. The overrepresentation of Vg12a was also evident in the LPS-induced BALB/c VH3H9 tg hybridoma panels (25) . Why this gene segment is overrepresented is unclear. Reports of overrepresentation of L chain gene segments include the observation that there is an increased frequency of Vg4 family rearrangements in pre-B cell lines (47) , and that particular VK4 members within the V~c4 family are preferentially employed (48) . The Vg12a overrepresentation we observe may be the consequence of specificity-independent mechanisms such as the frequency of rearrangements of this particular L chain gene, or the consequence of specificity-dependent (positive) selection in associ-A sequence was designated the same gene and given the same lowercase letter suffix if there were seven or fewer nucleotide differences (97.5% nucleotide similarity), with no more than four of these in framework regions. Although an arbitrary definition, for the most part sequences either fell into this definition or were quite clearly outside it. Framework (FW) and complementarity determining regions (CDRs) are shown above the sequences and separated by a space. The Vg12d sequences discussed in the text are boxed. Gene families were assigned based upon homology to published sequences (32) . The lowercase letter designation is used to distinguish among individual genes (e.g., Vg12a), and are the same as those used previously in the RALB/c VH3H9 tg mice, where appropriate (25) . Several sequences which were observed in the previous report of BALB/c VH3H9 tg mice (25) were not observed in the current study, such as VIc4a. JKs are assigned to the known BALB/c JK germline gene segments (55) . MRL-lpr/I F" mice have the JK2' allelic variant of Jg2 which has a serine at position 100 and a methionine at position 106 compared with the glycine and isoleucine of Jg2.
Substantial Overlap in V/c Gene Segment Use Between BALB/c and MRL.lpr/lpr

A. V karma amino acid seouences from VH3H9 t~ hvbrldomas
Note that JK2 and Jg2' occupy the same chromosomal position relative to the other JKs (56) . The backcross 2 BALB/c VH3H9 tg mouse used in this study carries both the BALB/c JK2 locus and a J locus containing the same allelic variant found in the MILL-lpr/Ipr mice which was most likely contributed by the SJL allele of the (C57Blx SJL)F1 VH3H9 tg founder (56) . ation with the VH3H9 tg. In addition to the VK12a, several other V K genes (e.g., 2a, 4f, 9c, 34a) are also present in both hybridoma panels (Figs. 3 A and 4 (Figs. 3 and 4) . Many of the L chains used in the HN set have been previously identified, paired with a variety of H chains, in anti-DNA Igs from several murine SLE models (Fig. 5) . This suggests that these L chains, like the VH3H9 H chain, have inherent DNA-binding ability. The fact that we can rescue VH3H9 tg plus endogenous L chain pairs that generate anti-HN Igs from MRL-Ipr/lpr VH3H9 tg mice rules out the trivial explanation that their absence in the BALB/c VH3H9 tg pands is the consequence of the inability of these H + L chain pairs to form. Instead, the absence of particular L chains from the BALB/c VH3H9 tg hybridomas suggests that B calls bearing these L chains with the VH3H9 tg are negatively selected as a consequence of their self-reactivity.
Analysis of the usage of the VA1 L chain gene segment in the hybridoma panels provides dear evidence that VL genes that can pair with VH3H9 to give anti-HN Igs are selected against in BALB/c mice but not in MRblpr/lpr mice. Transfection experiments using the VH3H9 H chain into a BALB/cderived cell line that expresses a germline Vkl have shown that VM/VH3H9 Igs are anti-HN (49) . Eight of nine A1-expressing hybridomas from the MRL-lt, r/lpr VH3H9 tg mice express a VA1/VH3H9 combination, and the hybridomas are anti-HN. In contrast, there is only one example of a VM/VH3H9 tg hybridoma retrieved from BALB/c VH3H9 tg mice. This hybridoma does not display HN reactivity, apparently due to coexpression of a K protein (Fig. 3 B) . One of the VM MRL-Ipr/1pr VH3H9 tg-derived hybridomas also coexpresses a K protein and is likewise not anti-HN (Fig. 3  B) . Although the mechanism by which coexpression of an additional L chain interferes with the anti-HN specificity of hybridomas that also contain the VM/VH3H9 combination has not been established, this example underscores that BALB/c VH3H9 tg mice can rearrange at least one anti-HN-associated gene (VM). However, its expression appears to be limited to B cells that coexpress an additional L chain that disrupts its specificity for DNA.
J K Gene Use in VH3H9 tg Hybridomas.
A second example that highlights that BALB/c VH3H9 tg mice have the genetic capacity to produce anti-HN Igs is the use of the VK12d gene segment. A set of hybridomas from both BALB/c and MRL1pr/llor VH3H9 tg mice use the same VK12d V gene segment but differ in their specifidty for DNA (Fig. 3 A) . Three of the four VK12d/VH3H9 tg hybridomas derived from the MRblpr/Ipr background are anti-HN. In contrast, the single VK12d/VH3H9 tg hybridoma derived from the BALB/c background only binds ssDNA, as does the fourth MRblpr/Ipr hybridoma. Although the VK12d V gene segments for all of these hybridomas are 100% identical at the nudeotide level over the region sequenced (compare VK12d sequences from Fig. 3 A) , there are differences in theJ K gene segments used.
The three anti-HN MRL-Ipr/llor VH3H9 tg hybridomas use JK2'. The ssDNA binding hybridoma from the BALB1 VH3H9 tg mouse uses VK12d recombined to a JK1, as does the ssDNA binding MRL3 hybridoma. As shown in Fig.  3 A, the BALB1 VH3H9 tg mouse can and does use JK2' with other VLs, but does not with VK12d, further underscoring the negative selection of B cells bearing the anti-HN specificity in nonautoimmune mice.
Several studies have proposed that developing B cells that are autoreactive can be rescued from deletion by revising their Ig receptors. The uncoupling of the fate of the B cell from its antigen receptor has been termed receptor editing (25, 45, 50) . We have evaluated the BALB1 VH3H9 tg hybridomas described in this study for evidence of receptor editing. Replacement of a primary K rearrangement with a secondary rearrangement on the same allele would predict the accumulation of 3' J KS in the nonantoreactive B cells (25, 50) . Indeed, a bias in the 3' JK5 gene segment usage was observed in an earlier examination of BALB/c VH3H9 tg-derived hybridomas and was, therefore, interpreted as evidence for receptor editing (25) . However, no 3' J K bias was observed in this current examination of K gene segment usage in BALB1 VH3H9 tg-derived hybridomas (Fig. 3) . It is possible that the different protocols used to generate the hybridoma panels may be responsible for this difference in J K gene segment usage: the earlier hybridomas were generated from LPSactivated B cells (25) , whereas the hybridomas reported here were derived from unmanipulated spleen cells. The data presented here do not suggest a role for receptor editing in the elimination of anti-HN cells from BALB/c mice. Tables 1 and 2 ). The role of Fas in murine lupus is unclear; it could be exerting its effects via the "auto-antigen" and/or directly in the autoreactive B cell. Recently, it was reported that the majority of auto-antigens targeted in SLE are found reorganized and clustered within distinct cell surface structures during cell death by apoptosis (52) . Given Fas' link to apoptosis (53) , a defective Fas may manifest itself as a defect in apoptosis. It has been proposed that failure of Fasmediated T cell apoptosis within the thymus of lpr/lpr mice may facilitate the persistence of autoreactive cells and may at the same time also deprive the animal of the "apoptotic" auto-antigens that serve as tolerogens (52) .
Is the Fas-defect in MRL-
We would extend this model to include an effect of the In conclusion, we hypothesize that the Ipr mutation may disrupt both the B cell's susceptibility to negative selection and the quality and quantity of the tolerogen. Both of these alterations may be required for the production of the specific set of autoantibodies found in MKL-Ipr/lpr mice.
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